- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-life cost-effectiveness of benralizumab in patients with severe asthma ; volume:22 ; number:1 ; day:27 ; month:5 ; year:2021 ; pages:1-14 ; date:12.2021
Respiratory research ; 22, Heft 1 (27.5.2021), 1-14, 12.2021
- Urheber
-
Padilla-Galo, A.
García-Ruiz, A. J.
Levy Abitbol, R. Ch
Olveira, C.
Rivas-Ruiz, F.
García-Agua Soler, N.
Pérez Morales, M.
Valencia Azcona, B.
Tortajada-Goitia, B.
Moya-Carmona, I.
Levy-Naon, A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-021-01758-0
- URN
-
urn:nbn:de:101:1-2021092320024542006243
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Padilla-Galo, A.
- García-Ruiz, A. J.
- Levy Abitbol, R. Ch
- Olveira, C.
- Rivas-Ruiz, F.
- García-Agua Soler, N.
- Pérez Morales, M.
- Valencia Azcona, B.
- Tortajada-Goitia, B.
- Moya-Carmona, I.
- Levy-Naon, A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness analysis of a state funded programme for control of severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Cost-effectiveness of activated protein C in real-life clinical practice
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
Cost-effectiveness analysis of a state funded programme for control of severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Cost-effectiveness of activated protein C in real-life clinical practice
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
Cost-effectiveness analysis of a state funded programme for control of severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Cost-effectiveness of activated protein C in real-life clinical practice
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia